PortfoliosLab logoPortfoliosLab logo
CH5.L vs. MWRD.L
Performance
Return for Risk
Drawdowns
Volatility
Dividends

Performance

CH5.L vs. MWRD.L - Performance Comparison

The chart below illustrates the hypothetical performance of a £10,000 investment in Amundi ETF MSCI Europe Healthcare UCITS ETF (CH5.L) and Amundi Index MSCI World (MWRD.L). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period


CH5.L

1D
3.21%
1M
1.61%
YTD
-3.01%
6M
-1.61%
1Y
8.05%
3Y*
-26.49%
5Y*
-13.43%
10Y*
-3.17%

MWRD.L

1D
1M
YTD
6M
1Y
3Y*
5Y*
10Y*
*Multi-year figures are annualized to reflect compound growth (CAGR)

CH5.L vs. MWRD.L - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
CH5.L
Amundi ETF MSCI Europe Healthcare UCITS ETF
-3.01%11.85%-63.23%5.38%1.64%17.03%3.58%24.30%0.41%-5.46%
MWRD.L
Amundi Index MSCI World
0.00%0.00%-1.27%17.50%-9.18%24.39%11.85%23.29%-4.10%6.52%

Correlation

The correlation between CH5.L and MWRD.L is 0.49, which is low. Their price movements are largely independent, making them effective diversification partners.


Correlation
Correlation (3Y)
Calculated over the trailing 3-year period

0.16

Correlation (5Y)
Calculated over the trailing 5-year period

0.31

Correlation (All Time)
Calculated using the full available price history since Jun 30, 2017

0.49

The correlation between CH5.L and MWRD.L shifts across timeframes, from 0.16 (3 years) to 0.49 (all time), reflecting how their relationship changes across market environments.

CH5.L vs. MWRD.L - Sectors Allocation Comparison


Sectors
CH5.L
MWRD.L

Industrials

37.9%
10.6%

Healthcare

28.0%
12.4%

Financial Services

18.5%
14.7%

Technology

15.7%
24.7%

Consumer Cyclical

6.6%
10.5%

Basic Materials

3.3%
3.8%

Consumer Defensive

1.8%
6.7%

Energy

1.5%
4.4%

Utilities

0.6%
2.4%

Real Estate

0.5%
2.4%

Communication Services

0.0%
7.5%

Industrials

CH5.L
37.9%
MWRD.L
10.6%

Healthcare

CH5.L
28.0%
MWRD.L
12.4%

Financial Services

CH5.L
18.5%
MWRD.L
14.7%

Technology

CH5.L
15.7%
MWRD.L
24.7%

Consumer Cyclical

CH5.L
6.6%
MWRD.L
10.5%

Basic Materials

CH5.L
3.3%
MWRD.L
3.8%

Consumer Defensive

CH5.L
1.8%
MWRD.L
6.7%

Energy

CH5.L
1.5%
MWRD.L
4.4%

Utilities

CH5.L
0.6%
MWRD.L
2.4%

Real Estate

CH5.L
0.5%
MWRD.L
2.4%

Communication Services

CH5.L
0.0%
MWRD.L
7.5%

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

CH5.L vs. MWRD.L — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

CH5.L
CH5.L Risk / Return Rank: 1717
Overall Rank
CH5.L Sharpe Ratio Rank: 1717
Sharpe Ratio Rank
CH5.L Sortino Ratio Rank: 1717
Sortino Ratio Rank
CH5.L Omega Ratio Rank: 1717
Omega Ratio Rank
CH5.L Calmar Ratio Rank: 1717
Calmar Ratio Rank
CH5.L Martin Ratio Rank: 1616
Martin Ratio Rank

MWRD.L
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

CH5.L vs. MWRD.L - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Amundi ETF MSCI Europe Healthcare UCITS ETF (CH5.L) and Amundi Index MSCI World (MWRD.L). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


CH5.LMWRD.LDifference
Sharpe ratioReturn per unit of total volatility

Sortino ratioReturn per unit of downside risk

Omega ratioGain probability vs. loss probability

1.10

Calmar ratioReturn relative to maximum drawdown

0.60

Martin ratioReturn relative to average drawdown

1.43

CH5.L vs. MWRD.L - Sharpe Ratio Comparison


Loading charts...

Sharpe Ratios by Period


CH5.LMWRD.LDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

0.49

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

-0.42

Sharpe Ratio (10Y)

Calculated over the trailing 10-year period

-0.13

Sharpe Ratio (All Time)

Calculated using the full available price history

0.02

Drawdowns

CH5.L vs. MWRD.L - Drawdown Comparison


Loading charts...

Drawdown Indicators


CH5.LMWRD.LDifference

Max Drawdown

Largest peak-to-trough decline

-70.04%

Max Drawdown (1Y)

Largest decline over 1 year

-13.44%

Max Drawdown (3Y)

Largest decline over 3 years

-70.04%

Max Drawdown (5Y)

Largest decline over 5 years

-70.04%

Max Drawdown (10Y)

Largest decline over 10 years

-70.04%

Current Drawdown

Current decline from peak

-64.16%

Average Drawdown

Average peak-to-trough decline

-14.80%

Ulcer Index

Depth and duration of drawdowns from previous peaks

5.61%

Volatility

CH5.L vs. MWRD.L - Volatility Comparison


Loading charts...

Volatility by Period


CH5.LMWRD.LDifference

Volatility (1M)

Calculated over the trailing 1-month period

5.66%

Volatility (6M)

Calculated over the trailing 6-month period

11.79%

Volatility (1Y)

Calculated over the trailing 1-year period

16.28%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

31.85%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

25.28%

CH5.L vs. MWRD.L - Expense Ratio Comparison

CH5.L has a 0.25% expense ratio, which is higher than MWRD.L's 0.08% expense ratio. However, both funds are considered low-cost compared to the broader market, where average expense ratios usually range from 0.3% to 0.9%.


Dividends

CH5.L vs. MWRD.L - Dividend Comparison

Neither CH5.L nor MWRD.L has paid dividends to shareholders.


Tickers have no history of dividend payments

Frequently Asked Questions


CH5.L and MWRD.L have a correlation of 0.49, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

On fees, MWRD.L is cheaper at 0.08% per year. The better choice depends on whether you care most about return, fees, risk, or income.

MWRD.L is cheaper with a 0.08% expense ratio, compared with 0.25% for CH5.L.

CH5.L is categorized as Health & Biotech Equities, while MWRD.L is Global Equities. CH5.L tracks MSCI World/Health Care NR USD, while MWRD.L tracks MSCI ACWI NR USD. Their fees differ too: 0.25% for CH5.L and 0.08% for MWRD.L.

Portfolio Optimizer

Find the right allocation for CH5.L and MWRD.L

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer